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Purpose: We developed and applied a method for providing regional spinal cord
hypothermia with epidural cooling (EC) during thoracoabdominal aneurysm (TAA)
repair. Preliminary results indicated significant reduction in spinal cord ischemic com-
plications (SCI), compared with historical controls, and a 5-year experience with EC was
reviewed.
Methods: From July 1993 to September 1998, 170 patients with thoracic aneurysms (n
= 14; 8.2%) or TAAs (types I and II, n = 83 [49%]; type III, n = 66 [39%]; type IV, n =
7 [4.1%]) were treated with EC. An earlier aneurysm resection was noted in 44% of
patients, an emergent operation was noted in 20% of patients, and an aortic dissection
was noted in 16% of patients. The EC was successful (mean cerebrospinal fluid [CSF]
temperature at cross-clamp, 26.4 ± 3°C) in 97% of cases, with all 170 patients included
in an intention-to-treat analysis. The operation was performed with a clamp/sew tech-
nique (98% patients) and selective (T9 to L1 region) reimplantation of intercostal ves-
sels. Clinical and EC variables were examined for association with operative mortality
and SCI by means of the Fischer exact test, and those variables with a P value less than
.1 were included in multivariate logistic regression analysis.
Results: The operative mortality rate was 9.5% and was weakly associated (P = .07) with
SCI; postoperative cardiac complications (odds ratio [OR], 35.3; 95% CI, 5.3 to 233; P
< .001) and renal failure (OR, 32.2; 95% CI, 6.6 to 157; P < .001) were the only inde-
pendent predictors of postoperative death. SCI of any severity occurred in 7% of cases
(type I/II, 10 of 83 [12%]; all other types, 2 of 87 [2.3%]), versus a predicted (Acher
model) incidence of 18.5% for this cohort (P = .003). Half the deficits were minor, with
good functional recovery, and devastating paraplegia occurred in three patients (2.0%).
Independent correlates of SCI included types I and II TAA (OR, 8.0; 95% CI, 1.4 to
46.3; P = .021), nonelective operation (OR, 8.3, 95% CI, 1.8 to 37.7; P = .006), over-
sewn T9 to L2 intercostal vessels (OR, 6.1; 95% CI, 1.3 to 28.8; P = .023), and postop-
erative renal failure (OR, 23.6; 95% CI, 4.4 to 126; P < .001). These same clinical vari-
ables of nonelective operations (OR, 7.7; 95% CI, 1.4 to 41.4; P = .017), oversewn T9
to L2 intercostal arteries (OR, 9.7; 95% CI, 1.5 to 61.2; P = .016), and postoperative
renal failure (OR, 20.8; 95% CI, 3.0 to 142.1; P = .002) were independent predictors
of SCI in the subgroup analysis of high-risk patients, ie, patients with type I/II TAA.
Conclusion: EC has been effective in reducing immediate, devastating, total paraplegia
after TAA repair. A strategy that combines the neuroprotective effect of regional cord
hypothermia, avoiding the sacrifice of potential spinal cord blood supply, and postoper-
ative adjuncts (eg, avoidance of hypotension, CSF drainage) appears necessary to mini-
mize SCI after TAA repair. (J Vasc Surg 2000;31:1093-102.)
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When compared with Crawford’s benchmark
series detailing experience with more than 1500
patients treated from 1960 to 1991,1 contemporary
reports from centers of excellence typically detail a
declining incidence of spinal cord ischemia after tho-
racoabdominal aneurysm (TAA) repair.2-8 In
Crawford’s report, the overall rate of ischemic spinal
cord complications was 16%, with half these patients
sustaining devastating total paraplegia. Alternatively,
recent experience, both from centers that have car-
ried on Dr Crawford’s work4,5 and other centers,
including our own, indicates that the overall risk of
cord ischemia has decreased to the 5% to 8%
range.2,3,6-8 These rather consistent results have
been achieved with a variety of surgical and adjunc-
tive methods designed to minimize cord ischemia,
which are reviewed elsewhere.9
Impressed with both a substantial body of exper-
imental work10-14 and the concept of regional spinal
cord hypothermia, we devised a method for provid-
ing hypothermia to that region of the cord that is at
risk for ischemic injury during TAA repair.15 The ini-
tial experience with this technique in our first 70
patients indicated a highly significant reduction in
spinal cord ischemia complications when compared
with institutional historical control subjects.16
However, that report contained a modest (35
patients) experience in those patients with type I/II
TAAs (ie, those at the highest risk for spinal cord
ischemia). In the present study, the results achieved
with epidural cooling (EC) in 170 patients over a 5-
year period are reviewed.
PATIENTS AND METHODS
From July 1993 to December 1998, 170
patients with descending thoracic aneurysms or
TAAs were treated (by six participating surgeons)
with the adjunctive use of intraoperative EC. This
represented 77% of all patients undergoing resection
of such lesions on the Vascular Surgery Service dur-
ing this interval. Patients who were not treated with
EC were typically those patients with type IV TAAs,
because of their perceived low risk for cord ischemia
(unless specifically requested by surgeon), or
patients in whom certain logistic considerations (eg,
active infection, rupture with hemodynamic instabil-
ity) precluded epidural/spinal catheter placement.
The EC was successful (cerebrospinal fluid [CSF]
temperature at or near the target range of 26°C) in
97% of patients in whom it was attempted, with all
patients included in an intention-to-treat analysis.
Aneurysms were classified as to extent by means
of the scheme devised by Crawford. In types I and II
TAAs, the entire descending aorta was resected with
a cross-clamp immediately proximal or distal to the
left subclavian artery. Type III TAA resection
encompassed at least the lower third of the descend-
ing aorta. Crawford extent was defined by means of
the replacement at our operation; for example, a
patient with a prior infrarenal graft requiring resec-
tion of the descending aorta and upper abdominal
aorta to the earlier graft was classified as extent I,
rather than extent II. Clinical and demographic data
for the study group are detailed in Table I. Note that
seven patients with type IV TAAs were included
after a specific surgeon’s request, because of their
perceived increased risk based on individual patient
considerations (typically multiple visualized inter-
costal vessels to be encompassed in the resection, or
an earlier proximal aortic graft). An emergent oper-
ation was defined as either a rupture or presentation
with acute back/abdominal pain that necessitated
observation in the intensive care unit (ICU), with
arterial catheter pressure monitoring and operation
within 48 hours of admission.
Surgery was performed in most patients with a
clamp/sew technique, usually without the adminis-
tration of systemic heparin. In four patients (sur-
geon’s preference), atriofemoral bypass with sequen-
tial clamping and distal aortic perfusion was used.
Perfusion of the renal arteries with a solution of iced
(4°C) Ringer’s lactate with methylprednisolone (1
gm/L) and mannitol (26 gm/L) was performed in
cases in which the renal artery orifices were accessi-
ble. Since July 1996, in-line mesenteric shunting was
used in type I/II TAAs after completion of the prox-
imal aortic anastomosis.17 Mannitol and furosemide
were administered before aortic cross-clamping.
Other adjuncts specific to spinal cord protection
included a selective approach to intercostal vessel
reconstruction and continuous monitoring of CSF
pressure for 24 to 48 hours after operation. CSF was
withdrawn on an as-needed basis to maintain a CSF
pressure of less than 12 mm Hg. Although the pos-
ture toward intercostal reconstruction varied among
individual surgeons, patent intercostal vessels in the
T8 to L1 region were reimplanted by means of a sep-
arate inclusion button or were preserved at anasto-
motic regions when technically feasible. With satis-
factory EC, intercostal reconstruction was some-
times deferred until completion of the visceral vessel
reconstructions. Left renal artery reconstruction was
typically accomplished with a side-arm graft.
Operative death was defined as any death within
60 days of surgery or any death that occurred while
the patient was hospitalized. Spinal cord ischemic
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complications were classified as immediate, when
deficits were noted when the patient awoke from
anesthesia, or as delayed, when patients were initial-
ly neurologically intact. All patients were awakened
in the operating room when their endotracheal
tubes were exchanged for single lumen tubes for an
initial neurologic evaluation of the lower extremities.
Major cardiac complications included cardiac death,
myocardial infarction, and arrhythmia requiring
intravenous therapy or transfer back to the ICU.
Major pulmonary complications included mechani-
cal ventilation for more than 72 hours postopera-
tively, reintubation or transfer back to the ICU for
respiratory failure, documented pneumonia, or the
need for tracheostomy. Clinically significant renal
failure consisted of (1) the need for dialysis; (2)
postoperative creatinine levels of 3.0 mg/dL or
more (in patients with normal baseline creatinine
levels); or (3) the doubling of baseline creatinine lev-
els for those patients with baseline creatinine levels
of 1.8 mg/dL or more.
Anesthesia management was supervised in all
cases by a dedicated vascular anesthesia team (J. K.
D., C. C.). The specifics of the epidural infusion sys-
tem have been described in earlier publications15
and did not change in the study interval. A standard
4F 40-cm epidural catheter for administration of
local anesthesia and infusion of iced (4°C) normal
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Table II. Intraoperative epidural cooling data
Baseline During cross-clamp End of operation
Core temperature (°C)
Mean ± SD (range) 36.0 ± 0.5 (34.6 to 37.3) 35.0 ± 1.0 (27.5 to 37.5) 34.6 ± 0.8 (32.3 to 36.8)
CSF temperature (°C)
Mean ± SD (range) 36.0 ± 0.9 (28.0 to 38.0) 26.4 ± 3.0 (21.1 to 37.4) 33.9 ± 1.2 (28.0 to 36.8)
CSF pressure (mm Hg)
Mean ± SD (range) 13.3 ± 4.5 (4.0 to 30.0) 35.1 ± 13.1 (7.0 to 90.0) 11.9 ± 5.2 (2.0 to 28.0)
CSF, Cerebrospinal fluid.
Table I. Demographic and clinical data for 170 patients treated with epidural cooling
N (%)
Mean age in years (range) 68.8 ± 10.6 (17 to 85)
Men 84 (49.4)
Women 86 (50.6)
Diabetes mellitus 12 (7.1)
History of hypertension 147 (86.5)
Creatinine level ≥ 1.8 mg/dL 16 (9.4)
Severe COPD (FeV1 < 50% predicted) 47 (27.6)
Coronary artery disease 95 (56)
Aneurysm extent
Type I 53 (31.2)
Type II 30 (17.6)
Type III 66 (38.8)
Type IV 7 (4.1)
Descending thoracic 14 (8.2)
Aneurysm pathology
Degenerative 135 (79.4)
Dissection (6 patients with Marfan Syndrome) 28 (16.4)
Mycotic 4 (2.4)
Aortitis 3 (1.8)
Patients with earlier aortic resections 75 (44)
Infrarenal AAA 45 (60)
Thoracoabdominal 13 (17)
Proximal thoracic 17 (23)
Clinical presentation
Elective operation 137 (80.6)
Emergent operation (includes rupture) 33 (19.4)
Ruptured aneurysm 20 (11.8)
AAA, Abdominal aortic aneurysm; COPD, chronic obstructive pulmonary disease; FeV1, forced expiratory volume in 1 second.
saline was inserted at the T10 to T12 level and
advanced cephalad 4 to 5 cm. A second 4F thermis-
tor catheter was placed 4 cm into the subarachnoid
space at the L3-4 interspace, permitting continuous
recording of CSF temperature and pressure. An arbi-
trary 30 to 40 mm Hg gradient was maintained
between the mean arterial and CSF pressures, par-
ticularly during the early stages of the infusion, to
safeguard against the potential deleterious effects of
CSF pressure elevation that occurs coincident with
the epidural infusion. The EC infusion was begun
well in anticipation of aortic cross-clamp application
(mean time, 94 ± 47.5 minutes; range, 17 to 248
minutes), because experience has indicated this
interval is necessary to achieve target CSF tempera-
tures. Proximal hypertension was controlled during
cross-clamp application with Na nitroprusside.
Intraoperative details referable to EC data were
retrieved from original strip chart recordings; clinical
and operative details (eg, management of intercostal
vessels) were obtained from hospital and operative
records or, for most patients (75%), from a prospec-
tively maintained database.
Statistical analyses were performed by using a
commercial software package (Statistical Analysis
System, SAS Institute, Cary, NC) on a UNIX work-
station (Sun Microsystems, Mountain View, Calif).
Fisher exact tests (for categorical variables) and two-
sample tests (for continuous variables) were first
used as a means of testing the association among a
variety of clinical variables and the end points of
spinal cord ischemic injury and operative mortality
univariately. Logistic regression models were used as
a means of examining the effects of these parameters
on outcomes simultaneously. The statistical signifi-
cance level was set at a P value of .05.
RESULTS
Intraoperative data. The EC was successful in
achieving the target range (25 to 28°C) CSF tem-
peratures before cross-clamp application in 166 of
170 patients. The infusions were discontinued in
three patients because of unacceptably high CSF
pressures (inability to perform EC infusion without
exceeding mean arterial pressure/CSF pressure gra-
dients; see the Methods section) coincident with the
infusions, and a fourth patient’s CSF temperature
could not be lowered below 31°C. None of these
patients sustained deficits. The data for core and
CSF temperature and CSF pressure during the
course of operation are displayed in Table II. There
were no differences in any of these parameters
among patients with different aneurysm extents.
The only significant difference in EC parameters
among different aneurysm extents was the total
duration of the EC, which varied as a function of the
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Table III. Management of intercostal vessels
Intercostal reconstruction Vessels oversewn
None Preserved Inclusion T4 to T8 T9 to L2
Cord injury n n % n % n % n % n %
TAA extent
Type I/II No 73 25 34 18 25 30 41.5 46 63.9 20 27.8
Yes 10 8 80 — — 2 20 8 80 6 60
All 83 32 38.6 19 22.9 32 38.5 55 66.3 26 31.3
Type III/IV No 72 34 47 25 35.2 13 18.4 1 1.4 20 28.2
Yes 1 — — 1 100 — — — — — —
All 73 34 47 26 35.6 13 18.4 1 1.4 20 27.5
Descending thoracic No 13 8 61.5 5 38.5 — — 7 53.8 1 7.7
Yes 1 1 100 — — — — — — — —
All 14 9 64.3 5 35.7 — — 7 50 1 7.1
Totals 170 75 44.1 50 29.4 45 26.5 63 37.1 47 27.6
Inclusion, Vessels reconstructed with inclusion anastomosis (only performed in T9-L1 region); Preserved, vessels preserved in beveled
proximal or distal aortic suture lines; TAA, thoracoabdominal aortic aneurysm.
Table IV. Major postoperative complications
n (%)
Operative mortality 16 (9.5)
Cardiac 18 (10)
Pulmonary 48 (28)
Renal failure* 16 (9.4)
Paraplegia/paraparesis 12 (7)
Stroke (any severity) 5 (3)
*See text definition of clinically significant renal failure.
complexity of the repair. As expected, patients with
isolated descending aneurysms had the shortest
infusion duration (mean time, 113.8 ± 42 minutes;
range, 25 to 199 minutes), whereas those patients
with extent II TAAs had the longest infusion dura-
tion (mean time, 207.7 ± 77.8 minutes; range, 90 to
403 minutes; P = .0013). There were no differences
in any parameter relative to CSF temperature or
pressure among those patients with, as opposed to
those without, spinal cord ischemic complications.
Intraoperative management of intercostal and
proximal lumbar vessels is displayed in Table III. In
general, intercostal vessels in the T4 to T8 zone are
oversewn, unless they are situated so as to be easily
preserved in a beveled proximal aortic anastomosis.
Data are displayed by means of aneurysm type and
for patients with and patients without spinal cord
ischemic complications. Note that both reconstruct-
ed and oversewn vessels are displayed in Table III,
and these two categories are not mutually exclusive
(ie, some vessels may have been preserved and oth-
ers oversewn in any individual patient). The tech-
nique of intercostal reconstruction varied with
aneurysm extent; for example, patients with type III
TAAs typically had vessels in the T8 to T10 region
preserved in a beveled proximal aortic anastomosis,
whereas patients with type I/II TAAs more often
had separate inclusion button anastomoses of these
vessels. Among patients with type I/II TAAs, 61%
had reconstruction or preservation of patent inter-
costal vessels. However, 31% of these patients had
sacrifice of at least some patent vessels in the T9 to
L2 region.
Operative results.The operative mortality rate
was 16 of 170 patients or 9.5%. Causes of death
were perioperative hemorrhage (2 patients), multi-
ple organ failure (5 patients), mesenteric ischemia (3
patients), respiratory failure (3 patients), cardiac
related (1 patient), and proximal aortic rupture (2
patients, 1 ruptured aneurysm and 1 clamp site rup-
ture). Major postoperative complications are sum-
marized in Table IV. Among a variety of preopera-
tive variables (age, diabetes mellitus, renal insuffi-
ciency, aneurysm extent, clinical presentation,
aneurysm pathology, earlier aortic graft), intraoper-
ative variables (operative and cross-clamp times,
blood turnover), and postoperative variables (com-
plications) examined for association with operative
mortality, only the presence of postoperative spinal
cord ischemic complications (P = .073), major car-
diac complications (P = .0004), and renal failure (P
< .001) correlate with operative mortality after uni-
variate analysis. Postoperative cardiac complications
(OR, 35.3; 95% CI, 5.3 to 233; P < .001) and renal
failure (OR, 32.2; 95% CI, 6.6 to 157.2; P < .001)
were the independent correlates of operative 
mortality.
Spinal cord ischemic complications. Paraplegia
or paraparesis of any severity occurred in 12 of 170
patients or 7%. Deficits clustered among those
patients with extent I/II TAAs, with 10 of 83
patients (12%) with such aneurysms sustaining
deficits. With a published predictive model18 for
spinal cord injury after TAA resection, the predicted
incidence for paraplegia/paraparesis for the present
patient cohort is 18.5%. The observed incidence of
7% is significantly (P = .003) less than that predict-
ed. Details of patients who sustained spinal cord
complications are presented in Table V. Note that
two thirds of deficits occurred in a delayed fashion,
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Table V. Details of patients with paraplegia/paraparesis
Patient Date of Aneurysm Clinical 
number surgery extent presentation Onset Deficit extent Outcome
1 10/5/94 I Elective Delay–72 hours Mild unilateral PP Alive, ambulatory at 5 years
2 10/14/94 III Elective Immediate Central cord syndrome Postoperative death
3 1/31/96 I–Ac dissect Rupture Delay–5 days Bilateral PP Ambulatory at 3.5 years
4 3/25/96 I Elective Delay–2 weeks Plegia Postoperative death
5 3/11/96 I Elective Delay–48 hours Plegia Postoperative death
6 10/31/96 II Rupture Immediate Arm weakness Alive at 3 years
7 12/06/96 I Elective Immediate Bilateral PP Ambulatory at 3 years
8 2/13/97 V–Mycotic Rupture Delay–24 hours Unilateral PP A + W at 2.5 years
9 7/30/97 II–Dissect Elective Delay–48 hours Bilateral PP Ambulatory, A + W at 2 years
10 9/24/97 I Rupture Delay–48 hours Unilateral PP Ambulatory, A + W at 2 years
11 8/12/98 II Rupture Immediate Unilateral PP* In a nursing home
12 8/26/98 II–Dissect Urgent Delay–72 hours Plegia Died at 6 months
Extent V, descending thoracic; Dissect, chronic dissection; Ac Dissect, acute dissection; Immediate, deficit present on awakening from
anesthesia; PP, paraparesis; Plegia, paraplegia; A + W, alive and well.
*Earlier dense hemiplegia from earlier stroke.
and devastating paraplegia occurred in only three
patients. Atypical proximal cord lesions occurred in
two patients. The univariate analysis of factors exam-
ined for association with paraplegia/paraparesis are
displayed in Table VI. After logistic regression analy-
sis, independent correlates of spinal cord ischemic
injury were type I/II TAA (vs all others; OR, 8.0;
95% CI, 1.4 to 46.3; P = .021), nonelective opera-
tion (OR, 8.3; 95% CI, 1.8 to 37.7; P = .006), over-
sewn T9 to L2 intercostal vessels (OR, 6.1; 95% CI,
1.3 to 28.8; P = .023), and postoperative renal fail-
ure (OR, 23.6; 95% CI, 4.4 to 126; P < .001). Non-
elective operation (OR, 7.7; 95% CI, 1.4 to 41.4; P =
.017), sacrifice of patent intercostal vessels in the T9
to L2 region (OR, 9.7; 95% CI, 1.5 to 61.2; P =
.016), and postoperative renal failure (OR, 20.8;
95% CI, 3.0 to 14.21; P = .002) were demonstrated
by means of a subgroup analysis confined to type
I/II TAAs to be independent correlates of cord
ischemia in patients with extent I/II TAAs. Specific
tenets of EC (ie, patients whose CSF temperature
and CSF pressures during the cross-clamp interval
were more than 2 standard deviation higher than the
mean) were not correlated with cord ischemic com-
plications.
DISCUSSION
Strategies to minimize spinal cord ischemia dur-
ing TAA repair can be broadly divided into surgical
or adjunctive measures to maintain cord blood sup-
ply and neuroprotective adjuncts intended to
increase the ischemic tolerance of the cord. In the
former category, distal aortic perfusion, intercostal
vessel reconstruction, and CSF drainage are widely
applied. Neuroprotective strategies applied clinically
include variations of hypothermia and endorphin-
receptor blockage.18 The provision of regional
hypothermia to the cord with EC has been an
important component in our overall operative
approach to TAA repair, which has continued to
emphasize operative expediency and simplicity, 
without circulatory assist devices, maintenance of
systemic normothermia,19 cold perfusion for renal
protection,20 and in-line mesenteric shunting to
minimize visceral ischemia.17 Thus, our clamp/sew
technique, with adjuncts directed against the major
complications of operation, achieves all the goals of
left-heart bypass/distal perfusion, and the compara-
tive results achieved with these techniques have been
reviewed in previous publications.2,9 We prefer the
neuroprotective effect of moderate hypothermia
because, irrespective of overall operative technique,
some obligatory ischemic interval of the critical
intercostal segment (T9 to L1)21 accompanies the
resection of types I and II and many type III TAAs.
Unfortunately, the time threshold for ischemia pro-
gressing to injury is unknown. The generally accept-
ed correlation of increasing cross-clamp time and
cord injury1,4,8,16,22 supports the intuitively logical
supposition that duration of ischemia is critical. The
lower limits of this time threshold are unknown, but
may be narrow in some patients. Grabitz et al,6 in a
study with evoked potential monitoring, reported
that permanent cord injury resulted when potentials,
which obliterated with cross-clamping, could not be
restored within 20 minutes. This supports our con-
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Table VI. Univariate analysis of variables examined for association with postoperative paraplegia/paraparesis
Paraplegia/paraparesis
No Yes
n = 158 n = 12
Variable n (%) n (%) P value
Preoperative
Age ≥ 70 years 81 (52) 9 (75) .14
Creatinine level > 1.8 mg/dL 15 (9.6) 1 (8.3) 1.0
TAA extent I/II 72 (46) 10 (83) .015
Elective operation 129 (82.7) 6 (50) .014
Aortic dissection 25 (15.8) 3 (25) .42
Intraoperative
Total operative time > 6 hours 33 (21.2) 3 (25) .72
Visceral clamp time > 1 hour 27 (17.3) 3 (25) .45
Blood loss > 3 L 51 (32.7) 4 (33.3) 1.0
T9 to L2 intercostal sacrifice 41 (26) 6 (50) .09
Hypotension 13 (8.3) 3 (25) .09
Postoperative
Renal failure 23 (14) 7 (58) .001
Cardiopulmonary/renal complications 65 (42) 8 (66.7) .13
tention that neuroprotective maneuvers during the
cross-clamp interval are an important component in
preventing cord injury.
Although this experience has apparently 
documented adequate cord protection from intra-
operative ischemia with regional hypothermia, our
findings also illustrate the necessity of perioperative
vigilance, because most deficits occurred in a
delayed fashion. The pathogenesis of delayed deficit
is debated. Safi et al23 and others have presented cir-
cumstantial evidence that postoperative spinal cord
swelling and its potential control with CSF drainage
are important in the genesis and prevention of
delayed deficit.24 Other authors have argued that
the clinical observation of delayed deficit represents
the evolution of neuronal changes resulting ulti-
mately from the intraoperative ischemic insult.25
Many authors have observed that delayed deficit is
often temporally associated with postoperative
hypotension, which is consistent with our previous
observations16 and is illustrated dramatically in two
patients (patients 3 and 4; Table V) in the present
series. We have observed such hypotensive episodes,
particularly during hemodialysis, to precipitate para-
plegia even weeks after clearly normal postoperative
lower-extremity neurologic function. It is clear that
scrupulous attention to and vigorous treatment of
perioperative hypotension from any cause are impor-
tant components in preventing delayed deficit.
Jacobs et al26 have recommended maintaining post-
operative blood pressures at levels determined by
means of intraoperative perfusion pressures demon-
strated to reverse changes in motor-evoked poten-
tials. With the same rationale of maintaining opti-
mum cord perfusion pressures, many authors use
intraoperative and perioperative CSF drainage for
cord protection with a variety of operative strategies.
Although this is supported by experimental27 and
uncontrolled clinical observations,3,5,23 earlier stud-
ies that specifically isolated this modality failed to
demonstrate the benefit of it.28,29 However, Coselli
et al30 recently reported a well-conducted, random-
ized prospective study demonstrating a significant
beneficial effect for CSF drainage. Although most
patients in the present series had perioperative mon-
itoring of CSF pressures, CSF drainage was used
episodically and only when CSF pressures greater
than 12 mm Hg were recorded. Our current prac-
tice is to begin continuous passive CSF drainage
immediately after discontinuation of the EC infusion
and to continue it for 48 to 72 hours postoperative-
ly. Previously, we emphasized that intraoperative ele-
vation of CSF pressure coincident with the EC infu-
sion presents the principal technical limitation to the
EC technique. One patient early in our experience
(patient 2; Table V) had very high CSF pressures
and awoke with a proximal central cord syndrome.
We cannot exclude a similar phenomenon in a sec-
ond patient (patient 6; Table V). As noted in Table
II, CSF pressures with EC are approximately two
times the baseline values after target temperatures
are achieved at cross-clamping. Our experience indi-
cates that CSF pressures in this range are innocuous,
at least with coincident cord cooling; however, the
cooling effect is indeed regional and directed toward
the region of the thoracolumbar cord that is at risk
for ischemic injury. Accordingly, careful attention to
the balance between systemic arterial and CSF pres-
sures (see the Methods section) are mandatory, and
the mechanics of managing CSF pressures have been
detailed.16
Similar to the experience of other authors3,31 and
our previous experience,2 operations that were car-
ried out in nonelective circumstances (with or with-
out frank rupture) were accompanied by an
increased risk of cord injury. The mechanism of this
effect is unknown and is not (at least in this series)
related to preoperative hemodynamic instability.
Furthermore, in addition to postoperative hypoten-
sion, delayed deficits often occurred in the setting of
other major postoperative complications, such as
renal failure and systemic sepsis. Only two patients in
this series had deficits (both minor), without the
associated issues of either acute presentation or
major postoperative complications.
Findings in our study about the importance of
intercostal vessel reconstruction are consistent with
those of other contemporary series in which operative
management of intercostal vessels is detailed. Svensson
et al32 reported the first such study, and although para-
plegia rates were highest among those patients with
critical intercostal zone intercostal vessel sacrifice, the
reconstruction of these vessels without other adjuncts
was still accompanied by unacceptable rates of cord
injury. More recently, multiple authors, in particular
those using evoked potential monitoring to guide seg-
mental vessel reconstruction, have demonstrated the
favorable impact of intercostal reconstruction.6,26,33,34
The present report provides perhaps unintentional ver-
ification of the importance of intercostal reconstruc-
tion, because the participating surgeons did not neces-
sarily adhere to the aggressive posture of intercostal
preservation favored by the senior author (R. P. C.). In
patients with extent I/II TAAs, our data indicate a
substantial negative effect of critical zone intercostal
sacrifice, with these patients having an eightfold
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increased risk of neurologic deficit. Traditionally, sur-
geons were faced with the dilemma of expending pre-
cious cross-clamp time to perform intercostal recon-
struction before visceral/renal vessel anastomosis.
Because the neuroprotective effect of cord cooling is
present in our system, we frequently occlude critical
intercostal ostia with balloon catheters and defer their
reconstruction until after visceral/renal vessel recon-
struction is completed. We also agree with Jacobs et
al26 that intercostal vessel ostia surrounded by calcific
or mushy plaque are best prepared for reconstruction
with local endarterectomy, after which a suitable anas-
tomosis can be completed.
The overall results in the present series for opera-
tive mortality and spinal cord ischemia are remark-
ably similar to other contemporary reports,3,8,30,33,34
despite a wide range of operative strategies and
adjuncts directed against spinal cord ischemia. This
institutional, multisurgeon experience can perhaps
not be expected to equate with overall results from
single-surgeon series. The favorable impact of EC on
spinal cord ischemic complications at our institution
has been evident in both an overall decrease in lower-
extremity neurologic deficits16 and a shift in the pat-
tern and severity of these deficits. Although EC
unfortunately does not eliminate the complication,
the clinical impact of cord ischemia has decreased,
with devastating flaccid paraplegia occurring in only
2% of patients. The impact of neurologic deficits on
early postoperative mortality has decreased with
time2; acceptable long-term functional results were
noted in seven of 12 patients who sustained postop-
erative deficits. Other authors have noted the favor-
able impact of adjuncts on the clinical severity of
spinal cord ischemic complications.8 This experience
emphasizes the importance of a multifaceted strategy
to prevent spinal cord ischemia. Specifically, such an
approach should include neuroprotection during
cross-clamping (achieved with EC in our system),
avoiding sacrifice of potential cord blood supply
(intercostal preservation), and adjuncts (eg, CSF
drainage) to minimize the delayed impact of transient
intraoperative spinal cord ischemia.
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DISCUSSION
Dr Darling (Albany, NY). Here is another superb pre-
sentation on a difficult subject that your group has shown
real interest and extensive experience. One of the ques-
tions I have is, do you have any rationale why you think
that you have changed the spectrum of the postoperative
neurologic deficits from early to late, and how long do
you leave in your spinal drainage catheters? Do you think
that may impact on your results?
Dr Cambria (Boston, Mass). We think the explanation
relates to the fact that there appears to be adequate pro-
tection from intraoperative ischemia with the epidural
cooling technique. The patient who awakens from anes-
thesia with devastating paraplegia has become distinctly
uncommon, and perhaps this experience teaches us more
about the importance of postoperative adjuncts. As I men-
tioned, and you question the policy of CSF drainage, for
most of this experience we were in the habit of monitor-
ing CSF pressures and would only withdraw CSF for pres-
sures greater than 12 to 15 mm Hg. Most patients, in fact,
will not be demonstrated to have elevated CSF pressures.
Following Joe Coselli’s very impressive randomized,
prospective study apparently showing benefit for CSF
drainage, we have instituted the passive system, set with a
continuous lumbar drain system at 10 mm Hg pressure
and leave that in for 48 hours postoperatively. It is truly
impressive—the volumes of CSF that can drain with that
sort of arrangement, generally 200 to 300 cc per day in
the perioperative period. We currently institute continu-
ous passive CSF drainage immediately after ceasing the
epidural infusion system, which is usually at the point of
restoration of lower extremity perfusion.
Dr Darling. Superb job.
Dr Cambria. Thank you.
Dr Jorgensen (Portland, Me). That was a very nice pre-
sentation with excellent results. You mentioned early on,
or at least I understood you to say, that you simplified
your technique somewhat for the cooling. I would be
interested in hearing a little bit more about that. Also,
how do you manage the delayed deficits?
Dr Cambria. The basics of the technique have not real-
ly changed in the 5 years of this study. What has changed is
the level of attention given to maintaining an appropriate
gradient between systemic arterial pressure and CSF pres-
sures that will rise coincident with the epidural infusion.
How we manage the delayed deficit has been not at all
consistent over the 5 years of this experience. When a
patient is noted to have a deficit occurring after operation,
the first thing is to say that we have noticed, as others
have, that perioperative hypotension is a real risk factor for
the development of delayed deficits. We have seen
patients, for example, crash on hemodialysis as long as 2 to
3 weeks after surgery and develop a deficit after weeks of
clearly normal neurologic function. The most important
thing to do is to be sure that the patient has adequate per-
fusion pressure. We maintain CSF drainage, as mentioned,
for 2 days. If for some reason patients do not have a
drainage catheter, they would get naloxone and CSF
drainage. The role of steroids is unknown. I cannot say I
have ever personally seen a patient in whom it did any
good.
Dr Brewster (Boston, Mass). Has your methodology
been adopted in other units across the country or around
the world to your knowledge?
Dr Cambria. The method is in use at the Mayo Clinic.
Over 100 cases have been done now. It has been used
irregularly at the Cleveland Clinic. There are other units in
London that have used it. I have not seen other published
results on it in the surgical literature.
Dr LoGerfo (Boston, Mass). Richard, congratulations
on a very excellent paper introducing this new technique.
It was not clear to me at the end how this compares in
type I and type II with recent reports of using only spinal
cord drainage.
Dr Cambria. The overall incidence of neurologic deficit
in patients with type I and type II aneurysm was 11%. If
you aspire to the most recently published material from
Amsterdam using distal aortic perfusion, intraoperative
evoked potential monitoring, and CSF drainage, those
investigators have published the most impressive results in
the literature so far for an overall deficit rate of 3%. In the
type I and type II patients, our overall results are quite
similar to that reported from Houston and the other alter-
nate method advocated by Charles Acher from Wisconsin
(ie, CSF drainage and naloxone).
Dr LoGerfo. Do you use distal perfusion?
Dr Cambria. No, we do not. As mentioned in the pre-
sentation, all but four of these operations were carried out
with a clamp and sew and adjunct technique.
Dr Brewster. Richard, many members of this society may
most commonly encounter so-called type IV aneurysms
involving the visceral arteries but not extending to the tho-
racic aorta. Is epidural cooling necessary for such patients?
Dr Cambria. There were seven patients in the experi-
ence with type IV aneurysm. We have, by and large, not
used the technique in type IV aneurysms because of per-
ceived and, in fact, demonstrated actual low risk for the
development of the complication in patients whose
aneurysm extends just to the diaphragm with a clamp
immediately above the celiac. Even if intercostal vessels are
occluded during the cross-clamp period in those opera-
tions, they can typically be reconstructed in a beveled
proximal suture line. So the seven patients with type IV
aneurysm included in this study were specifically request-
ed because the surgeon felt there were factors, either inter-
costal vessels or a prior aneurysm resection proximally,
that increased the risk for spinal cord ischemia.
Dr Cantelmo (Boston, Mass). Do you think there
would be any benefit to continuing the cooling beyond
the period that you now use it, possibly even into the peri-
operative period? Is that technically feasible?
Dr Cambria. It is an interesting question, Dr
Cantelmo. Thank you. The problem is mainly a logistical
one. We have considerable trepidation about continuing a
method that has the potential for increasing CSF pressure
in any environment other than the operating room. The
answer is no, we have not continued it. The experimental
literature suggests that hypothermic protection can blunt
the hyperemic phase of cord reperfusion. I think many of
the delayed deficits are related to that, but we have not
used the technique out of the operation room. The infu-
sion needs fairly close direct attending anesthesia supervi-
sion in the operating room, and I do not think it would be
feasible to continue that for hours afterwards in the inten-
sive care unit.
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THE DARTMOUTH ATLAS OF VASCULAR CARE
The Joint Council of the SVS/ISCVS has sponsored a project with the Center for the Evaluative
Clinical Sciences at Dartmouth Medical School to develop a national Atlas of Vascular Health Care.
The Dartmouth group is led by Dr John Wennberg, who pioneered geographic small area analysis, the
analytical foundation for the Dartmouth Atlas series. Based on 1996-1997 Medicare Part B (CPT)
claims data, the Atlas contains a comparison of the rates of peripheral vascular surgery and interven-
tional procedures across the 306 major hospital referral regions of the United States. The Atlas also
identifies the types of specialists performing these procedures in different referral regions (cardiolo-
gists, radiologists, cardiothoracic, general and board-certified vascular surgeons).
Procedures analyzed in the Atlas include carotid endarterectomy; abdominal aortic aneurysm
repair; lower extremity arterial bypass graft, angioplasty/stenting, and amputation; hemodialysis
access; and other miscellaneous procedures. Outcome of carotid and aortic surgery is analyzed by spe-
cialty and by surgeon volume. Data tables and a computer diskette provide detailed information con-
cerning rates and provider specialty type for each vascular procedure in each local region. A sophisti-
cated model of vascular workforce projection is also included. 
The Joint Council was pleased to provide financial support for this effort to better understand the
delivery of vascular health care in the United States. The Atlas is now available and may be ordered
from the publisher, the American Hospital Association (1-800-242-2626). Because of their sponsor-
ship, there is a reduced price for SVS/ISCVS members.
